TABLE — AFC — HD AMS Life Science — 2025/26 group results

Oct 15 (Reuters)- AFC-HD AMS Life Science CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) Year ended Year ended Year to NEXT Aug 31, 2026 Aug 31, 2025 Aug 31, 2027 YEAR LATEST YEAR-AGO COMPANY COMPANY RESULTS RESULTS FORECAST H1 FORECAST Sales 34.32 32.66 35.47 17.61 (+5.1 pct) (+8.2 pct) (+3.3 pct) (+4.5 pct) Operating 2.46 2.41 2.62 1.27 (+1.9 pct) (+25.7 pct) (+6.9 pct) (+1.7 pct) Recurring 2.39 2.44 2.51 1.22 (-2.2 pct) (+27.2 pct) (+5.1 pct) (+1.7 pct) Net 1.20 1.45 1.66 815 mln (-17.2 pct) (+15.7 pct) (+38.3 pct) (+1.8 pct) EPS 82.89 yen 102.98 yen 113.88 yen 56.03 yen EPS Diluted — 102.97 yen — Ann Div 40.00 yen 34.00 yen 44.00 yen -Q2 div 18.00 yen 16.00 yen 22.00 yen -Q4 div 22.00 yen 18.00 yen 22.00 yen NOTE — AFC-HD AMS Life Science. *Net profit row denotes profit attributable to owners ofthe parent To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2927.T